Nanopore direct RNA sequencing reveals unique molecular fingerprints for early cancer detection
Different types of cancer have unique molecular ‘fingerprints’ which are detectable in early stages of…
Browsing: cancer diagnostics
Aventa FusionPlus test that detects gene fusions, translocations, and rearrangements receives favorable pricing determination from CMS
Aventa™ Genomics, LLC, a clinical laboratory deploying 3D genomics to improve patient outcomes, and a…
Wobble Genomics’ new tech demonstrates the power of RNA sequencing in identifying rare RNA transcript variants
Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, will…
NeoGenomics Receives New York State Approval for NGS Solid Tumor Test
NeoGenomics, a leading oncology testing services company, today announced that the New York State Department of…